Envoy Medical regains compliance with Nasdaq minimum bid price requirement
COCH•Envoy Medical regained compliance with Nasdaq’s minimum bid price requirement after its Class A common stock closed at or above $1 for 10 consecutive trading days.
1. Compliance restored
Envoy Medical said it regained compliance with Nasdaq Listing Rule 5550(a)(1) after its Class A common stock closed at or above $1 per share for 10 consecutive trading days. A 1-for-10 reverse stock split took effect October 26, 2026, and the stock will continue trading on the Nasdaq Capital Market as COCH.
